HomeEPRX • NASDAQ
add
Eupraxia Pharmaceuticals Inc
Previous close
$7.51
Day range
$7.25 - $7.69
Year range
$2.68 - $9.32
Market cap
627.11M CAD
Avg Volume
270.16K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.16M | 116.03% |
Net income | -16.71M | -122.55% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -16.11M | -116.46% |
Effective tax rate | -0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 80.56M | 143.38% |
Total assets | 86.15M | 146.55% |
Total liabilities | 5.70M | 83.80% |
Total equity | 80.45M | — |
Shares outstanding | 61.50M | — |
Price to book | 7.44 | — |
Return on assets | -45.27% | — |
Return on capital | -47.76% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -16.71M | -122.55% |
Cash from operations | -9.73M | -62.87% |
Cash from investing | -193.30K | -341.76% |
Cash from financing | 1.49M | -95.30% |
Net change in cash | -8.40M | -134.35% |
Free cash flow | -4.80M | -48.71% |
About
Founded
2011
Headquarters
Website
Employees
33
